- Individualized treatment of opioid dependence with weekly and monthly Buvidal ® was well-tolerated and effective, with a high (73.6%) patient retention across the 48-week study - 83.4% of ...

A "game-changer" jab to treat opioid dependence could ease pressure on health care services, outperforming other standard treatments, a new report involving University of Hertfordshire academics ...

Phase 3 post-hoc analysis indicates less fentanyl and overall illicit opioid use for weekly/monthly buprenorphine depots versus daily standard treatment in a difficult to treat patient population LUND ...

LUND, Sweden, Nov. 26, 2019 /PRNewswire/ -- Camurus announced today topline results from the 24-week, randomized, controlled, open-label, DEBUT study of weekly and monthly Buvidal® (prolonged-release ...

LUND, Sweden, Nov. 22, 2018 /PRNewswire/ -- Camurus announced today that the European Commission (EC) has approved weekly and monthly Buvidal® (prolonged release buprenorphine) for the treatment of ...

Camurus, a Swedish research-based pharmaceutical company, announced that the European Commission (EC) has approved weekly and monthly Buvidal (prolonged release buprenorphine) for the treatment of ...

Exclusive: Fears that US companies may withdraw more medicines as global markets react to policy changes by the Trump administration ...

To overcome problematic opioid use, traditional forms of opioid substitution therapy, such as methadone and oral buprenorphine, have become valuable tools. Research shows that patients receiving ...

The EU’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of a new dose of Camurus’ prolonged-release injection opioid dependence treatment. Buvidal, which contains ...

Camurus AB, a Swedish, science-led biopharmaceutical company, announced that the Swiss agency for therapeutic products, Swissmedic, has approved weekly and monthly Buvidal prolonged release ...

The full CMI on the next page has more details. If you are worried about being given this medicine, speak to your doctor, nurse practitioner or pharmacist. Buvidal contains the active ingredient ...